biomodal (Cambridge Epigenetix)

biomodal is a life-sciences technology and analytics company that specializes in multi-omics solutions. Founded in 2012 and headquartered in Saffron Walden, Essex, the company integrates genetic and epigenetic information from low-input DNA samples. This approach enables insights into cancer, neurodegenerative diseases, ageing, and precision medicine. The company's primary product is the duet multiomics solution evoC, which captures a comprehensive view of the genome from minimal DNA samples. This platform distinguishes between canonical bases and key epigenetic markers, allowing for high-accuracy analysis without the need for complex bioinformatics. biomodal's tools are particularly valuable in cancer research, neurodegenerative disease studies, ageing research, and precision medicine applications. With a team of around 82 employees, biomodal continues to advance biotechnology research and development.